Logo

Johns Hopkins

Top Five Articles on 360Dx Last Week: Changes at QuidelOrtho; Diasorin Seeks FDA Clearance; More

Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.

Johns Hopkins Researchers Use Machine Learning for Early Detection of Ovarian Cancer
Premium

The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.

Previse Awarded $1.8M NIH Grant to Develop Esophageal Cancer Test

The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.

Alveo Tech, Global Virus Network, Johns Hopkins Partner on POC MDx Assay Development Program

The partners intend to equip labs in their networks with Alveo test systems for assay development.

Previse Completes Validation Study of Barrett's Esophagus Test, Sees Path to Guideline Inclusion
Premium

The epigenetic risk stratification test demonstrated the potential to decrease surveillance among some patients and increase it among others.

Aug 27, 2024

JAMA Study Finds Black Patients Less Likely to Receive Dx Testing When Released From ER

May 13, 2024

Top Five Articles on 360Dx Last Week: New Day Dx's CRC Screening Plans; New BARDA Accelerator; More

May 9, 2024

Danaher, Johns Hopkins Partner to Develop Methods for Detecting Mild TBI

Nov 17, 2023

Previse Ramps up Commercialization of Barrett's Esophagus Test, Developing Esophageal Cancer Assay
Premium

Sep 29, 2023

Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium

Aug 22, 2023

Delfi Diagnostics Boosts Lung Cancer Detection Power With Addition of Mutational Profiles
Premium

Aug 4, 2023

Preprint Casts Doubt on Study Underpinning Microbiome-Based Cancer Dx Test From Micronoma
Premium

Jul 28, 2023

Gates Foundation Awards Multiple Grants for Omics, Dx Projects in July

Jul 14, 2023

Yale, Johns Hopkins Researchers Create Urine Test for Kidney Inflammation Biomarker
Premium

Apr 27, 2023

Quest Diagnostics to Acquire Liquid Biopsy Firm Haystack Oncology for up to $450M

Mar 31, 2023

Kephera Diagnostics Gets $3M NIH Grant for Chagas Disease Test

Nov 18, 2022

Liver Cancer Detection Score Developed With Machine Learning Analysis of Blood Plasma DNA Fragments

Nov 17, 2022

Haystack Oncology to Debut Hypersensitive Residual Cancer Test Based on Hopkins Tech
Premium

Nov 16, 2022

Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round

Jun 7, 2022

Circulating Tumor DNA Utility in Post-Surgery Stage II Colon Cancer Cemented by New Data
Premium

Mar 31, 2022

New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch
Premium

Mar 31, 2022

Johns Hopkins Developing Single-Use SARS-CoV-2 Test Leveraging Nanotech, Spectroscopy
Premium

Oct 7, 2021

Post-IPO, LumiraDx Pushes Adoption of POC Instrument, Eyes Test Menu Expansion
Premium

May 11, 2021

GBS Developing Organic Thin-Film Transistor Tech to Detect SARS-CoV-2 Antibodies, Monitor Glucose
Premium

Apr 29, 2021

Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays